The progress in the new drug development by the knowledge of hydatid's genomics / 医学研究生学报
Journal of Medical Postgraduates
;
(12): 220-224, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-700806
ABSTRACT
As a local parasitic disease in Qinghai,Tibet,Xinjiang and other places,cerebral hydatid disease has high morbidity and mortality.At present,the main drug for Echinococcosis is benzimidazole.However,due to the lack of efficacy and side effects of these drugs,we urgently need to develop new drugs.In this paper,we gives a brief introduction of the application of genomics,stem cells and signaling pathway knowledge in developing new drugs of hydatid,which aims to understand the limitations of current hydatid medication,summarize the research progress of new drugs,put forward the potential research direction,prompting the development of new drug research.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Medical Postgraduates
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS